A study by Von Hoff et al. showed that treating human tumor cells with low concentrations of hydroxyurea accelerated the loss of extrachromosomally amplified oncogenes, such as MYC, which was correlated with a dramatic reduction in tumorigenicity [127]. Here, MYC is linked to neoplasm.